Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

Int J Tuberc Lung Dis. 2014 Feb;18(2):160-7. doi: 10.5588/ijtld.13.0369.


Setting: Armenia, a country with a high prevalence of drug-resistant tuberculosis (DR-TB).

Objective: To identify factors related to default from DR-TB treatment in Yerevan.

Design: Using a retrospective cohort design, we compared defaulters with patients who were cured, completed or failed treatment. Patients who initiated DR-TB treatment from 2005 to 2011 were included in the study. A qualitative survey was conducted including semi-structured interviews with defaulters and focus group discussions with care providers.

Results: Of 381 patients, 193 had achieved treatment success, 24 had died, 51 had failed treatment and 97 had defaulted. The number of drugs to which the patient was resistant at admission (aRR 1.16, 95%CI 1.05-1.27), the rate of treatment interruption based on patient's decision (aRR 1.03, 95%CI 1.02-1.05), the rate of side effects (aRR 1.18, 95%CI 1.09-1.27), and absence of culture conversion during the intensive phase (aRR 0.47, 95%CI 0.31-0.71) were independently associated with default from treatment. In the qualitative study, poor treatment tolerance, a perception that treatment was inefficient, lack of information, incorrect perception of being cured, working factors and behavioural problems were factors related to treatment default.

Conclusion: In addition to economic reasons, poor tolerance of and poor response to treatment were the main factors associated with treatment default.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Armenia
  • Drug Resistance, Bacterial*
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Male
  • Medication Adherence*
  • Middle Aged
  • Patient Dropouts
  • Perception
  • Qualitative Research
  • Remission Induction
  • Retrospective Studies
  • Risk Factors
  • Socioeconomic Factors
  • Time Factors
  • Treatment Failure
  • Tuberculosis, Multidrug-Resistant / diagnosis
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / microbiology


  • Antitubercular Agents